Promacta Powder, For Suspension
Product Images NDC 0078-0972

Product Visual Gallery

This gallery contains 17 technical images submitted to the FDA as part of the official labeling for Promacta (NDC 0078-0972). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Novartis Pharmaceuticals Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Eltrombopag Olamine Chemical Structure (Promacta Spl Graphic 01)

Chemical structure of eltrombopag olamine, the active ingredient in PROMACTA tablets, showing its molecular composition including multiple rings and functional groups with two amine groups attached.*

FDA Label Image

Promacta-ifu-illustrations-1 (Promacta Spl Graphic 02)

PROMACTA (eltrombopag olamine) oral tablet film-coated packaging label showing a single-dose foil pouch. The image displays a plain, rectangular white packet with a tapered end and sealed edges, associated with unit-dose packaging by Novartis Pharmaceuticals Corporation.*

FDA Label Image

Promacta-ifu-illustrations-2 (Promacta Spl Graphic 03)

Illustration of a pharmaceutical bottle with a screw-on lid and a tethered cap. The image labels the 'Cap' attached to the 'Lid' of the bottle, which is commonly used for dispensing oral medication tablets or capsules.*

FDA Label Image

Promacta-ifu-illustrations-3 (Promacta Spl Graphic 04)

An instructional diagram of a syringe labeled with parts including the plunger, barrel, and syringe tip. The barrel features volume markings from 5 ml to 20 ml for measuring liquid dosage.*

FDA Label Image

Promacta-ifu-illustrations-4 (Promacta Spl Graphic 05)

An instructional illustration showing a hand holding a syringe being filled with liquid from a cup marked with a 20 mL volume line. The image demonstrates measuring or drawing up 20 mL of liquid into the syringe.*

FDA Label Image

Promacta-ifu-illustrations-5 (Promacta Spl Graphic 06)

An instructional illustration showing a person drawing liquid from a small bottle using a syringe. One hand holds the bottle steady while the other pulls the syringe plunger to withdraw the liquid. The image depicts a step in medication preparation or administration.*

FDA Label Image

Promacta-ifu-illustrations-6 (Promacta Spl Graphic 07)

An illustration showing two hands: one hand holding an open bottle filled with tablets, and the other hand pouring tablets from a strip into the bottle. The image depicts the handling and transferring of oral tablets.*

FDA Label Image

Promacta-ifu-illustrations-7 (Promacta Spl Graphic 08)

An instructional illustration showing a hand holding a small brown bottle with a blue cap and a child-resistant safety lock. Arrows around the bottle indicate it should be twisted or turned to open or close it.*

FDA Label Image

Promacta-ifu-illustrations-8 (Promacta Spl Graphic 09)

An instructional illustration depicting a person holding a syringe-like device with a reservoir and a cap, demonstrating the preparation or administration of a liquid medication. The image shows the hands positioning the device, possibly for injecting or dispensing the medication.*

FDA Label Image

Promacta-ifu-illustrations-9 (Promacta Spl Graphic 10)

An instructional illustration showing hands using a syringe to draw liquid from a small bottle. The syringe is held vertically above the bottle, which has a cap with a tube extending into the liquid inside. This diagram likely demonstrates preparation or administration steps involving a syringe and vial.*

FDA Label Image

Promacta-ifu-illustrations-10 (Promacta Spl Graphic 11)

An illustration showing the oral administration of a liquid medication to a child using a dosing syringe. A hand holds the syringe, placed at the child's mouth, ready for delivery.*

FDA Label Image

Promacta For Oral Suspension 12.5 mg 30 Packets Outer Carton (Promacta Spl Graphic 12)

Packaging label for PROMACTA 12.5 mg (eltrombopag) for Oral Suspension. The label shows the product name, strength, dosage form as oral suspension in 30 packets. It includes dosing instructions, handling warnings, and storage conditions. The labeler is Novartis Pharmaceuticals Corporation with locations in New Jersey noted. The design includes purple and green accents with medication image and regulatory details.*

FDA Label Image

Promacta 25mg 30 Count Label (Promacta Spl Graphic 13)

PROMACTA (eltrombopag) 25 mg oral film-coated tablets packaging label, showing the Novartis Pharmaceuticals Corporation as the labeler. The label includes a note that each tablet contains eltrombopag diamine equivalent to 25 mg eltrombopag free acid. The package contains 30 tablets with instructions to dispense with a Medication Guide and storage conditions included.*

FDA Label Image

Promacta 50mg 30 Count Label (Promacta Spl Graphic 14)

Promacta (eltrombopag) Tablets 50 mg film-coated oral tablets labeled for prescription use. The label shows storage instructions, dosage form, strength, and a 30-tablet count. Manufactured by Novartis Pharmaceuticals Corporation with product origin stated as Ireland.*

FDA Label Image

Promacta 75mg 30 Count Label (Promacta Spl Graphic 15)

PROMACTA 75 mg film-coated tablets label by Novartis Pharmaceuticals Corporation. The oral tablet contains eltrombopag olamine equivalent to 75 mg of eltrombopag free acid. The package contains 30 tablets, with storage instructions and dispensing guidelines noted on the label.*

FDA Label Image

Promacta 12.5mg 30 Count Label (Promacta Spl Graphic 16)

PROMACTA (eltrombopag) Tablets 12.5 mg film-coated oral tablets. The label shows the product name, strength, dosage form, and a statement that each tablet contains eltrombopag olamine equivalent to 12.5 mg of eltrombopag free acid. The label also indicates storage instructions, dispensing information, and the manufacturer as Novartis Pharmaceuticals Corporation. The package contains 30 tablets.*

FDA Label Image

Promacta For Oral Suspension 12.5 mg 30 Packets Outer Carton (Promacta Spl Graphic 17)

Flat layout of the cardboard carton for Promacta 25 mg (eltrombopag) oral suspension packets. The label shows the proprietary name Promacta and generic name eltrombopag with the 25 mg strength highlighted in red. The label states it is for oral suspension and includes 30 packets per carton. The packaging includes dosage and storage instructions, a barcode, and Novartis Pharmaceuticals Corporation as the labeler.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.